Inventor
GURER CAGAN
US100 patents
⚠️ This page may combine multiple inventors who share the name “GURER CAGAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
REGENERON PHARMA
46 patentsUS9006511B2Apr 14, 2015
Human lambda light chain mice
REGENERON PHARMA45 citations99
US9226484B2Jan 5, 2016
Human lambda light chain mice
REGENERON PHARMA31 citations98
US9206263B2Dec 8, 2015
Method of making antibodies using a human lambda light chain mouse
REGENERON PHARMA33 citations98
US9163092B2Oct 20, 2015
Hybrid light chain mice
REGENERON PHARMA36 citations98
US9150662B2Oct 6, 2015
Hybrid light chain mice
REGENERON PHARMA31 citations98
US9066502B2Jun 30, 2015
Hybrid light chain mice
REGENERON PHARMA36 citations98
US9029628B2May 12, 2015
Human lambda light chain mice
REGENERON PHARMA37 citations98
US8847005B2Sep 30, 2014
Genetically modified major histocompatibility complex mice
REGENERON PHARMA33 citations98
US9462794B2Oct 11, 2016
Non-human animals having a humanized signal-regulatory protein gene
REGENERON PHARMA28 citations97
US9193977B2Nov 24, 2015
Non-human animals having a humanized signal-regulatory protein gene
REGENERON PHARMA29 citations97
US9127292B2Sep 8, 2015
Non-human animals having a humanized signal-regulatory protein gene
REGENERON PHARMA28 citations97
US9113616B2Aug 25, 2015
Genetically modified mice having humanized TCR variable genes
REGENERON PHARMA67 citations97
US9206261B2Dec 8, 2015
Method of making antibodies using a human lambda light chain mouse
REGENERON PHARMA19 citations96
US9206262B2Dec 8, 2015
Method of cloning a lambda light chain variable domain using a human lambda light chain mouse
REGENERON PHARMA20 citations96
US10561124B2Feb 18, 2020
Humanized light chain mice
REGENERON PHARMA12 citations94
US9204624B2Dec 8, 2015
Non-human animals with modifed immunoglobulin heavy chain sequences
REGENERON PHARMA30 citations94
US9043996B2Jun 2, 2015
Genetically modified major histocompatibility complex animals
REGENERON PHARMA31 citations94
US10154658B2Dec 18, 2018
Genetically modified major histocompatibility complex mice
REGENERON PHARMA16 citations93
US9850462B2Dec 26, 2017
Human lambda light chain mice
REGENERON PHARMA9 citations93
US9844212B2Dec 19, 2017
Human lambda light chain mice
REGENERON PHARMA15 citations93
US9622459B2Apr 18, 2017
Humanized light chain mice
REGENERON PHARMA19 citations93
US9540452B2Jan 10, 2017
Human lambda light chain mice
REGENERON PHARMA13 citations93
US9399683B2Jul 26, 2016
Human lambda light chain mice
REGENERON PHARMA14 citations93
US9394373B2Jul 19, 2016
Human lambda light chain mice
REGENERON PHARMA13 citations93
US9334333B2May 10, 2016
Hybrid light chain mice
REGENERON PHARMA12 citations93
US9089599B2Jul 28, 2015
Low affinity FCGR deficient mice
REGENERON PHARMA9 citations93
US9056130B2Jun 16, 2015
Humanized Fc gamma R mice
REGENERON PHARMA9 citations93
US9901083B2Feb 27, 2018
Non-human animals having a humanized signal-regulatory protein gene
REGENERON PHARMA8 citations92
US9706759B2Jul 18, 2017
Humanized light chain mice
REGENERON PHARMA11 citations92
US11259510B2Mar 1, 2022
Humanized T cell mediated immune responses in non-human animals
REGENERON PHARMA8 citations86
US11019810B2Jun 1, 2021
Non-human animals having a humanized signal-regulatory protein gene
REGENERON PHARMA6 citations84
US10426848B2Oct 1, 2019
Humanized FcγR mice
REGENERON PHARMA3 citations84
US10266803B2Apr 23, 2019
Human lambda light chain mice
REGENERON PHARMA4 citations84
US10246509B2Apr 2, 2019
Restricted immunoglobulin heavy chain mice
REGENERON PHARMA6 citations84
US10206379B2Feb 19, 2019
Non-human animals having a humanized signal-regulatory protein gene
REGENERON PHARMA4 citations84
US9930871B2Apr 3, 2018
Non-human animals with modified immunoglobulin heavy chain sequences
REGENERON PHARMA7 citations84
US9848587B2Dec 26, 2017
Humanized T cell co-receptor mice
REGENERON PHARMA6 citations84
US9730435B2Aug 15, 2017
Non-human animals having a humanized a proliferation-inducing ligand gene
REGENERON PHARMA5 citations84
US9700027B2Jul 11, 2017
Non-human animals having a humanized signal-regulatory protein gene
REGENERON PHARMA7 citations84
US9686970B2Jun 27, 2017
Mice that make VL binding proteins
REGENERON PHARMA10 citations84
US9687566B2Jun 27, 2017
Low affinity FCGR deficient mice
REGENERON PHARMA6 citations84
US9629347B2Apr 25, 2017
Non-human animals having a humanized B-cell activating factor gene
REGENERON PHARMA6 citations84
US9615550B2Apr 11, 2017
Genetically modified major histocompatibility complex mice
REGENERON PHARMA12 citations84
US9591835B2Mar 14, 2017
Genetically modified major histocompatibility complex animals
REGENERON PHARMA11 citations84
US9585373B2Mar 7, 2017
Genetically modified major histocompatibility complex mice
REGENERON PHARMA8 citations84
US9474255B2Oct 25, 2016
Non-human animals having humanized Fc-gamma receptors
REGENERON PHARMA6 citations84
MACDONALD LYNN
4 patentsUS9035128B2May 19, 2015
Hybrid light chain mice
MACDONALD LYNN59 citations98
US9012717B2Apr 21, 2015
Human lambda light chain mice
MACDONALD LYNN61 citations98
US9516868B2Dec 13, 2016
Mice that make VL binding proteins
MACDONALD LYNN14 citations92
US8658154B2Feb 25, 2014
Humanized FcγR mice
MACDONALD LYNN9 citations92
Showing the top 50 of 100 patents by PatentIndex Score.